Klcm Advisors, Inc. Eli Lilly & CO Transaction History

Klcm Advisors, Inc.

$820 Million
Q3 2024

A detailed history of Klcm Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Klcm Advisors, Inc. holds 6,847 shares of LLY stock, worth $5.24 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

6,847

Previous 7,222 5.19%

Holding current value

$5.24 Million

Previous $6.54 Million 7.22%

% of portfolio

0.74%

Previous 0.83%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $289,552 - $360,007	-375 Reduced 5.19%	6,847 $6.07 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $36,243 - $45,452	50 Added 0.7%	7,222 $6.54 Million
Q1 2024 May 16, 2024	SELL	$592.2 - $792.28 $385,522 - $515,774	-651 Reduced 8.32%	7,172 $5.58 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $597,141 - $703,950	1,137 Added 17.01%	7,823 $4.56 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $64,335 - $88,696	148 Added 2.26%	6,686 $3.59 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $108,378 - $144,914	309 Added 4.96%	6,538 $3.07 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $27,956 - $32,833	90 Added 1.47%	6,229 $2.14 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $16,077 - $18,733	50 Added 0.82%	6,139 $2.25 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $13,341 - $15,204	45 Added 0.74%	6,089 $1.97 Million
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $26,479 - $31,090	-95 Reduced 1.55%	6,044 $1.96 Million
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $46,938 - $58,332	200 Added 3.37%	6,139 $1.76 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $44,970 - $55,808	200 Added 3.48%	5,939 $1.64 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $17,152 - $22,186	95 Added 1.68%	5,739 $1.32 Million
Q4 2020 Jan 26, 2021	BUY	$130.46 - $172.63 $4,044 - $5,351	31 Added 0.55%	5,644 $953,000
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $833 - $1,031	7 Added 0.12%	5,613 $779,000
Q4 2019 Feb 04, 2020	SELL	$106.92 - $132.43 $35,604 - $44,099	-333 Reduced 5.61%	5,606 $737,000
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $3,656 - $4,267	-33 Reduced 0.55%	5,939 $658,000
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $27,606 - $32,587	372 Added 6.64%	5,972 $462,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,600	5,600 $461,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $727B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klcm Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Klcm Advisors, Inc. with notifications on news.

Account

Klcm Advisors, Inc. Eli Lilly & CO Transaction History